Intrinsic Value of S&P & Nasdaq Contact Us

Danaher Corporation DHR-PB NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
62/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Danaher Corporation (DHR-PB) generated $2.12B in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $371M, free cash flow was $1.75B.

Free cash flow margin was 25.5% of revenue. Cash conversion ratio was 1.77x, indicating earnings are backed by cash.

The company returned $226M in dividends and $25M in share buybacks to shareholders during the quarter.

Criteria supported by this page:

  • HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
  • MOAT (92/100, Pass) — $1.75B (25.5% margin) supports a durable competitive advantage
  • INCOME (55/100) — Cash conversion ratio was 1.77x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 62/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
62/100
SG Score
View full scorecard →
VALUE
15/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
55/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
92/100
Proven by this page
GROWTH
15/100
→ Income
~
INCOME
55/100
→ Income
Danaher Corporation Cash Flow History
Metric TTM Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Operating Cash Flow $6.42B$2.12B$1.66B$1.34B$1.3B
Capital Expenditure $-1.16B$-371M$-292M$-248M$-245M
Free Cash Flow $5.26B$1.75B$1.37B$1.09B$1.05B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message